Related Experiment Video
Updated: Sep 22, 2025

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
Expression and Potential Biomarkers of Regulators for M7G RNA Modification in Gliomas
Zhen Chen1, Zhe Zhang1, Wei Ding2
1Department of Neurosurgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Abstract:
Gliomas are the most frequent primary malignant brain tumors of the central nervous system, causing significant impairment and death. There is mounting evidence that N7 methylguanosine (m7G) RNA dysmethylation plays a significant role in the development and progression of cancer. However, the expression patterns and function of the m7G RNA methylation regulator in gliomas are yet unknown. The goal of this study was to examine the expression patterns of 31 critical regulators linked with m7G RNA methylation and their prognostic significance in gliomas. To begin, we systematically analyzed patient clinical and prognostic data and mRNA gene expression data from The Cancer Genome Atlas (TCGA) and the Gene Expression Omnibus (GEO) databases. We found that 17 key regulators of m7G RNA methylation showed significantly higher expression levels in gliomas. We then divided the sample into two subgroups by consensus clustering. Cluster 2 had a poorer prognosis than cluster 1 and was associated with a higher histological grade. In addition, cluster 2 was significantly enriched for cancer-related pathways. Based on this discovery, we developed a risk model involving three m7G methylation regulators. Patients were divided into high-risk and low-risk groups based on risk scores. Overall survival (OS) was significantly lower in the high-risk group than in the low-risk group. Further analysis showed that the risk score was an independent prognostic factor for gliomas.
Insights
N7 methylguanosine (m7G) RNA methylation regulators are dysregulated in gliomas, impacting patient prognosis. A new risk model using three m7G regulators can predict glioma patient survival outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Gliomas are primary malignant brain tumors with poor outcomes.
- N7 methylguanosine (m7G) RNA dysmethylation is implicated in cancer development.
- The role of m7G RNA methylation regulators in gliomas is largely unknown.
Purpose of the Study:
- To investigate the expression patterns of 31 m7G RNA methylation regulators in gliomas.
- To determine the prognostic significance of these regulators in glioma patients.
- To develop a risk model for predicting glioma prognosis based on m7G regulators.
Main Methods:
- Systematic analysis of clinical and mRNA gene expression data from TCGA and GEO databases.
- Consensus clustering to stratify glioma patients into subgroups.
- Development and validation of a risk score model using m7G methylation regulators.
Main Results:
- 17 out of 31 m7G RNA methylation regulators were significantly upregulated in gliomas.
- Consensus clustering identified two subgroups; Cluster 2 showed poorer prognosis and higher histological grade, enriched in cancer pathways.
- A risk model based on three m7G regulators stratified patients into high-risk and low-risk groups with significantly different overall survival (OS).
Conclusions:
- m7G RNA methylation regulators are dysregulated in gliomas and associated with tumor progression.
- The developed risk score is an independent prognostic factor for glioma patients.
- Targeting m7G RNA methylation may offer potential therapeutic strategies for gliomas.
Related Concept Videos
MicroRNAs
Regulation of Expression at Multiple Steps
Regulated mRNA Transport
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
What is Gene Expression?

